Study reinforces bad news about estrogen-progestin pill therapy

10/6/2004 |

Researchers said those pills double the chances of postmenopausal women developing dangerous blood clots, with the risk increasing even more for overweight patients and those over the age of 60. Researchers reached to their conclusion after looking more closely at data from the Women's Health Initiative study, which initially pointed to signs the combination raised the risk of deep vein thrombosis.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI